<DOC>
	<DOCNO>NCT01103960</DOCNO>
	<brief_summary>The primary objective trial demonstrate fixed-dose combination telmisartan 80mg plus amlodipine 5mg ( T80/A5 ) superior amlodipine 5mg ( A5 ) reduce seat trough diastolic blood pressure ( DBP ) 8 week .</brief_summary>
	<brief_title>An Eight-week Randomized , Double-blind Study Evaluate Efficacy Safety Fixed-dose Combinations T80+A5 Versus A5 Monotherapy Patients With Hypertension Who Fail Respond Adequately Treatment With A5 Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Inclusion criterion : 1. diagnosis essential hypertension 2. failure respond adequately six week treatment amlodipine 5 mg monotherapy 3. provision write informed consent Exclusion criterion : 1. clinical condition , opinion investigator , would allow safe completion protocol safe administration telmisartan amlodipine plan duration trial ( e.g . population label either product recommend utilization )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>